Endometrial Cancer
839
213
279
307
Key Insights
Highlights
Success Rate
83% trial completion
Published Results
85 trials with published results (10%)
Research Maturity
307 completed trials (37% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.7%
65 terminated out of 839 trials
82.5%
-4.0% vs benchmark
6%
54 trials in Phase 3/4
28%
85 of 307 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 307 completed trials
Clinical Trials (839)
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Comparison of Lee-Huang Point and Umbilical Entry for Laparoscopic Success in Endometrial Cancer Patients
Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
DESTINY-PANTUMOUR04
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
Orlistat Plus Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical Hyperplasia
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
A Phase 1 Study of the Safety and Tolerability of CTX-10726
Low-Residue Diet Versus Rectal Enema Before Laparoscopic Surgery for Endometrial Cancer
Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers